40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze analyst forecasts for the company and compare them with competitors.
4.23B
Better than VET's estimated revenue of 1.08B.
3.38B
Better than VET's estimated ebitda of 535.16M.
2.14
Better than VET's estimated eps of 0.62.
2.09B
Better than VET's estimated net income of 100.73M.
2.12B
Better than VET's estimated ebit of 173.32M.
375.17M
Worse than VET's estimated sg&a expense of 86.74M.
Analyze DCF forecasts for the company and compare them with competitors.
10.66B
Better than VET's revenue of 1.52B.
-14.47%
Better than VET's revenue growth rate of -40.89%.
4.71B
Better than VET's ebitda of 359.67M.
44.17%
Better than VET's ebitda margin of 23.62%.
2.87B
Better than VET's ebit of -133.66M.
26.87%
Better than VET's ebit margin of -8.78%.
1.84B
Worse than VET's depreciation of 493.33M.
3.00M
Worse than VET's total cash of 97.93M.
0.03%
Worse than VET's cash as percentage of revenue of 6.43%.
1.34B
Worse than VET's receivables of 168.17M.
12.62%
Worse than VET's receivables as percentage of revenue of 11.04%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
586.00M
Worse than VET's accounts payable of 248.74M.
5.50%
Better than VET's payables as percentage of revenue of 16.34%.
-2.74B
Better than VET's capital expenditure of -408.58M.
-25.74%
Worse than VET's capex as percentage of revenue of -26.83%.
11.89%
Better than VET's weighted average cost of capital (wacc) of 13.75%.
16.87%
Worse than VET's cost of equity of 16.56%.
5.31%
Better than VET's cost of debt of 9.00%.
2.64
Worse than VET's beta of 2.58.
263.90M
Worse than VET's diluted shares outstanding of 163.72M.
6.68B
Worse than VET's total debt of 655.60M.
10.03B
Better than VET's total equity of 1.42B.
16.71B
Better than VET's total capital of 2.07B.
39.98%
Worse than VET's debt weighting of 31.64%.
60.02%
Worse than VET's equity weighting of 68.36%.
2.38B
Better than VET's ebiat of -114.11M.
1.81B
Better than VET's unlevered free cash flow of 209.58M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-12.22B
Worse than VET's terminal value of 5.64B.
-10.96B
Worse than VET's enterprise value of 4.48B.
6.68B
Worse than VET's net debt of 557.67M.
-17.64B
Worse than VET's equity value of 3.92B.
-66.84
Worse than VET's equity value per share of 23.97.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
